XOOMAR
Get a free API key

Intensity Therapeutics (INTS)

Intensity Therapeutics on one page: short interest, daily short volume, fails to deliver, earnings dates and insider trades. Listed on Nasdaq.

Download CSV

88K

Short interest

settlement 2026-10-15

3.0

Days to cover

+0.9 days vs prior

55.3%

Short share of volume

2026-11-02

3,584

Fails to deliver

settlement 2026-10-14

Thu 5 Nov

Next earnings

estimated date

$0

Insider flow, 90 days

0 buys, 0 sells

As of 2026-11-02.

Short interest

FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSON

As of 15 October 2026, short interest in INTS is 87,767 shares, up 56,469 shares over the last month. Over the last 48 readings it ranged from 31,298 shares (15 September 2026) to 16,769,283 shares (31 October 2025). The latest reading sits at the bottom of that range. At the reported average volume of 29K shares a day that is 3.0 days to cover.

Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/ints" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
PreviewDark previewAdd ?theme=dark to the src for a dark chart.
SettlementShares shortChangeAvg daily volumeDays to cover
2026-10-1587,767+129.4%28,9053.04
2026-09-3038,253+22.2%17,8442.14
2026-09-1531,298-36.0%12,0482.60
2026-08-3148,911-40.2%45,1861.08
2026-08-1481,764+19.6%28,8132.84
2026-07-3168,355-58.0%23,3782.92
2026-07-15162,597+28.6%53,8473.02
2026-06-30126,421+117.2%76,3771.66
2026-06-1558,214-22.7%34,3581.69
2026-05-2975,310-0.0%20,6503.65
2026-05-1575,334+3.3%30,7212.45
2026-04-3072,900+10.5%35,0932.08
2026-04-1565,989+8.0%24,3332.71
2026-03-3161,082+15.8%23,7602.57
2026-03-1352,723-26.8%30,6601.72
2026-02-2771,994-93.3%101,9261.00
2026-02-131,077,181-7.0%1,601,1081.00
2026-01-301,158,529-21.5%1,310,8341.00
2026-01-151,475,864-20.9%1,055,0851.40
2025-12-311,865,400-36.7%1,545,5261.21
2025-12-152,946,226+17.5%4,621,7461.00
2025-11-282,507,610-30.1%1,639,8341.53
2025-11-143,588,277-78.6%10,189,8131.00
2025-10-3116,769,283+644.0%137,823,2741.00
2025-10-152,253,998+160.3%8,304,1301.00
2025-09-30865,945+240.6%1,667,5921.00
2025-09-15254,272-62.1%4,515,8461.00
2025-08-29670,859-32.1%3,988,2331.00
2025-08-15987,865+4.5%5,160,1241.00
2025-07-31945,059+143.9%6,007,7701.00
2025-07-15387,444-6.2%4,527,5721.00
2025-06-30412,820-37.4%2,117,4541.00
2025-06-13659,567+42.9%3,048,0821.00
2025-05-30461,635+192.8%1,841,8601.00
2025-05-15157,645-9.8%175,1181.00
2025-04-30174,784+320.7%597,6891.00
2025-04-1541,542-27.5%12,2273.40
2025-03-3157,293+10.4%54,5071.05
2025-03-1451,912+4.0%17,3183.00
2025-02-2849,914-3.1%17,8932.79
2025-02-1451,513-3.0%31,6751.63
2025-01-3153,083-10.6%32,3201.64
2025-01-1559,391+52.6%52,1141.14
2024-12-3138,925-37.4%36,8521.06
2024-12-1362,208+60.9%59,2291.05
2024-11-2938,675-10.6%23,3011.66
2024-11-1543,250-2.3%14,1703.05
2024-10-3144,277+7.7%13,1883.36

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 2 November 2026, the short share of INTS volume is 55.3%, up 14.9 points over the last five sessions. Over the last 30 readings it ranged from 8.8% (9 October 2026) to 89.3% (2 October 2026). The latest reading is 5.2 points above the 30-session average of 50.2%, on 3K shares reported.

DateShort volumeTotal volumeShort shareExempt
2026-11-022K3K55.3%0
2026-10-306K11K51.2%0
2026-10-292K4K55.9%0
2026-10-287735521.7%0
2026-10-276K12K46.7%0
2026-10-262K5K40.5%0
2026-10-233K5K66.3%0
2026-10-223K4K58.4%0
2026-10-214K5K71.8%0
2026-10-205651K40.0%0
2026-10-199884K23.4%0
2026-10-165K21K22.3%0
2026-10-153K4K69.6%0
2026-10-146K14K43.7%0
2026-10-1365K84K77.3%10,172
2026-10-1227K32K85.6%615
2026-10-0988210K8.8%0
2026-10-087K18K36.5%0
2026-10-074K8K44.9%0
2026-10-061K5K25.7%0
2026-10-059K16K59.2%0
2026-10-029K10K89.3%0
2026-10-014K6K78.6%0
2026-09-3010K16K61.1%4,204
2026-09-2914K20K72.1%100
2026-09-281K15K9.6%0
2026-09-253K5K66.5%0
2026-09-242K4K46.7%0
2026-09-231982K12.8%20
2026-09-225K8K64.2%0

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 14 October 2026, the fails-to-deliver balance in INTS is 3,584 shares, up 3,570 shares over the last settlement date. Over the last 30 readings it ranged from 5 shares (17 July 2026) to 9,372 shares (28 August 2026).

SettlementShares failedPriceValue
2026-10-143,584$3.55$13K
2026-10-0814$3.80$53
2026-10-05402$3.44$1K
2026-09-15201$3.98$800
2026-09-14825$4.02$3K
2026-09-09201$4.09$822
2026-09-03500$4.00$2K
2026-08-316,040$4.25$26K
2026-08-289,372$4.27$40K
2026-08-27470$4.53$2K
2026-08-26632$4.90$3K
2026-08-213,954$4.88$19K
2026-08-13316$4.16$1K
2026-08-05121$4.18$506
2026-08-0360$4.15$249
2026-07-27288$4.46$1K
2026-07-20105$4.75$499
2026-07-175$4.90$25
2026-07-16481$4.84$2K
2026-07-14879$4.92$4K
2026-07-13268$4.78$1K
2026-07-105,106$4.91$25K
2026-07-091,935$4.90$9K
2026-07-08130$4.78$621
2026-07-07436$4.52$2K
2026-07-06449$4.24$2K
2026-07-023,741$4.15$16K
2026-06-291,466$4.10$6K
2026-06-256,488$4.08$26K
2026-06-241,849$4.00$7K

Insider trades

SEC Form 4, newest first. JSON

No open-market insider trades were reported for INTS in the last 90 days. The most recent filings are listed below. Latest filing: Wesolowski John M (Principal Accounting Officer) on 2026-06-30.

DateInsiderTitleTypeSharesPriceValueOwned after
2026-06-30Wesolowski John MPrincipal Accounting OfficerGrant4K$3.48$13K7K
2026-06-30Talamo JosephChief Financial OfficerGrant1K$3.48$4K2K
2026-03-26BENDER LEWIS HPresident and CEOGrant38K$6.11$231K119K
2025-12-31Wesolowski John MPrincipal Accounting OfficerGrant9K$0.26$2K85K
2025-12-31Talamo JosephChief Financial OfficerGrant14K$0.26$4K29K
2025-06-30Wesolowski John MPrincipal Accounting OfficerGrant70K$0.26$18K76K
2025-06-30Talamo JosephChief Financial OfficerGrant14K$0.26$4K14K
2024-06-05Wesolowski John MPrincipal Accounting OfficerExercise or conversion1K$4.00$4K7K

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

What this page is

Intensity Therapeutics in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Intensity Therapeutics (INTS), SEC CIK 1567264, listed on Nasdaq. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest
FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
Daily short volume
FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
Fails to deliver
SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-14.JSON and CSV
Earnings dates
SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-11.JSON and CSV
Insider trades
SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-06-30.JSON and CSV
Company record
EDGAR filing index for CIK 1567264Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits
10 requests a minute without a key, 30 with a free key from a free account.

How to read it

  • Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
  • Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
  • Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Other company pages

Datasets

Frequently Asked Questions

How much of INTS is sold short?
87,767 shares were held short at the 2026-10-15 settlement, 3.0 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is INTS's daily short volume?
On 2026-11-02, 1,922 of the 3,473 INTS shares reported to FINRA were sold short, 55.3% of the day's reported volume. Short volume is a flow for one day, not a position.
Does INTS have fails to deliver?
The SEC's latest file shows 3,584 INTS shares failed to deliver at settlement 2026-10-14. Fails are reported per settlement date and published twice a month with a lag.
Are INTS insiders buying or selling?
No open-market insider trades were reported for INTS in the last 90 days. The most recent filings are listed below. Latest filing: Wesolowski John M (Principal Accounting Officer) on 2026-06-30.

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.